Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oligodendroglia | 8 | 2022 | 37 | 2.260 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 7 | 2020 | 67 | 1.900 |
Why?
|
| Interferon Regulatory Factor-1 | 5 | 2012 | 10 | 1.800 |
Why?
|
| Interferon-gamma | 4 | 2012 | 82 | 0.950 |
Why?
|
| Multiple Sclerosis | 6 | 2022 | 107 | 0.900 |
Why?
|
| Myelin Sheath | 4 | 2022 | 26 | 0.740 |
Why?
|
| Apoptosis | 3 | 2010 | 205 | 0.620 |
Why?
|
| Demyelinating Diseases | 2 | 2022 | 15 | 0.570 |
Why?
|
| Neuromyelitis Optica | 2 | 2019 | 7 | 0.570 |
Why?
|
| Mice | 10 | 2022 | 1461 | 0.550 |
Why?
|
| Animals | 13 | 2022 | 3780 | 0.540 |
Why?
|
| Signal Transduction | 4 | 2020 | 447 | 0.490 |
Why?
|
| Aquaporin 4 | 2 | 2019 | 7 | 0.450 |
Why?
|
| Inflammation | 2 | 2012 | 284 | 0.430 |
Why?
|
| Aquaporins | 1 | 2012 | 7 | 0.410 |
Why?
|
| Escherichia coli Proteins | 1 | 2012 | 12 | 0.410 |
Why?
|
| Demyelinating Autoimmune Diseases, CNS | 1 | 2011 | 2 | 0.370 |
Why?
|
| Immunomodulation | 1 | 2011 | 7 | 0.360 |
Why?
|
| Neuroglia | 1 | 2011 | 49 | 0.360 |
Why?
|
| Immunologic Factors | 3 | 2019 | 34 | 0.360 |
Why?
|
| Cells, Cultured | 6 | 2020 | 539 | 0.350 |
Why?
|
| STAT1 Transcription Factor | 1 | 2010 | 2 | 0.340 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 2 | 2007 | 4 | 0.330 |
Why?
|
| Stem Cells | 1 | 2010 | 41 | 0.330 |
Why?
|
| Mice, Inbred C57BL | 5 | 2022 | 435 | 0.330 |
Why?
|
| Natalizumab | 2 | 2019 | 21 | 0.320 |
Why?
|
| Mice, Transgenic | 4 | 2012 | 225 | 0.310 |
Why?
|
| Cell Differentiation | 2 | 2022 | 135 | 0.280 |
Why?
|
| Repressor Proteins | 1 | 2006 | 37 | 0.260 |
Why?
|
| Carrier Proteins | 1 | 2006 | 106 | 0.250 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 2 | 2019 | 24 | 0.240 |
Why?
|
| Wound Healing | 1 | 2005 | 159 | 0.220 |
Why?
|
| Central Nervous System | 3 | 2010 | 59 | 0.210 |
Why?
|
| Cardiac Glycosides | 1 | 2022 | 1 | 0.200 |
Why?
|
| Filgrastim | 2 | 2019 | 5 | 0.200 |
Why?
|
| Caspase 1 | 2 | 2012 | 16 | 0.180 |
Why?
|
| Female | 10 | 2022 | 15730 | 0.180 |
Why?
|
| Receptors, Interleukin-12 | 1 | 2020 | 16 | 0.170 |
Why?
|
| Flow Cytometry | 2 | 2011 | 116 | 0.170 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2020 | 26 | 0.170 |
Why?
|
| Mice, Knockout | 2 | 2011 | 316 | 0.160 |
Why?
|
| Immunosuppressive Agents | 1 | 2019 | 140 | 0.150 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 619 | 0.150 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 117 | 0.150 |
Why?
|
| JC Virus | 1 | 2019 | 98 | 0.150 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 1 | 2019 | 113 | 0.140 |
Why?
|
| Recombinant Proteins | 2 | 2020 | 213 | 0.140 |
Why?
|
| Pericytes | 2 | 2007 | 7 | 0.130 |
Why?
|
| Humans | 9 | 2020 | 28436 | 0.130 |
Why?
|
| Structural Homology, Protein | 1 | 2012 | 5 | 0.100 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2012 | 9 | 0.100 |
Why?
|
| Cross Reactions | 1 | 2012 | 12 | 0.100 |
Why?
|
| HEK293 Cells | 1 | 2012 | 67 | 0.100 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 160 | 0.100 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 199 | 0.100 |
Why?
|
| Rabbits | 1 | 2012 | 185 | 0.100 |
Why?
|
| Immunoglobulin G | 1 | 2012 | 95 | 0.100 |
Why?
|
| Up-Regulation | 2 | 2010 | 177 | 0.100 |
Why?
|
| Electrophoresis | 1 | 2011 | 6 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 139 | 0.090 |
Why?
|
| Fatal Outcome | 1 | 2011 | 57 | 0.090 |
Why?
|
| Male | 7 | 2020 | 15291 | 0.090 |
Why?
|
| Rats | 2 | 2010 | 678 | 0.090 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 362 | 0.090 |
Why?
|
| Janus Kinases | 1 | 2010 | 1 | 0.090 |
Why?
|
| eIF-2 Kinase | 1 | 2010 | 6 | 0.090 |
Why?
|
| Cell Death | 1 | 2010 | 46 | 0.080 |
Why?
|
| DNA | 1 | 2010 | 104 | 0.080 |
Why?
|
| Bone Marrow | 1 | 2010 | 79 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2010 | 116 | 0.080 |
Why?
|
| Adult | 5 | 2020 | 8107 | 0.080 |
Why?
|
| Middle Aged | 4 | 2019 | 9269 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2010 | 165 | 0.080 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2007 | 8 | 0.070 |
Why?
|
| Chemokines | 1 | 2007 | 21 | 0.070 |
Why?
|
| Antibody Formation | 1 | 2007 | 18 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2007 | 48 | 0.070 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2006 | 1 | 0.070 |
Why?
|
| Spinal Cord | 1 | 2007 | 85 | 0.070 |
Why?
|
| Cell Survival | 1 | 2006 | 120 | 0.060 |
Why?
|
| Oligodendrocyte Transcription Factor 2 | 1 | 2005 | 2 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2005 | 6 | 0.060 |
Why?
|
| Prostaglandin D2 | 1 | 2005 | 2 | 0.060 |
Why?
|
| Cell Hypoxia | 1 | 2005 | 11 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2005 | 172 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 155 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 274 | 0.050 |
Why?
|
| Models, Biological | 1 | 2005 | 326 | 0.050 |
Why?
|
| Cuprizone | 1 | 2022 | 1 | 0.050 |
Why?
|
| Digoxin | 1 | 2022 | 3 | 0.050 |
Why?
|
| Drug Repositioning | 1 | 2022 | 5 | 0.050 |
Why?
|
| Interleukin-23 | 1 | 2020 | 18 | 0.040 |
Why?
|
| Th17 Cells | 1 | 2020 | 30 | 0.040 |
Why?
|
| Interleukin-12 | 1 | 2020 | 38 | 0.040 |
Why?
|
| Protein Binding | 1 | 2020 | 132 | 0.040 |
Why?
|
| Hematologic Agents | 1 | 2019 | 3 | 0.040 |
Why?
|
| Antilymphocyte Serum | 1 | 2019 | 4 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2019 | 5 | 0.040 |
Why?
|
| Cyclophosphamide | 1 | 2019 | 51 | 0.040 |
Why?
|
| Time Factors | 2 | 2019 | 1491 | 0.040 |
Why?
|
| Salvage Therapy | 1 | 2019 | 35 | 0.040 |
Why?
|
| Rituximab | 1 | 2019 | 49 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2019 | 169 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2019 | 80 | 0.040 |
Why?
|
| Recurrence | 1 | 2019 | 322 | 0.040 |
Why?
|
| Disease Progression | 1 | 2019 | 717 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 1143 | 0.030 |
Why?
|
| Young Adult | 1 | 2019 | 2069 | 0.030 |
Why?
|
| Plasma | 1 | 2010 | 19 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2010 | 48 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2010 | 59 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 57 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2010 | 59 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 1663 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 96 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 3612 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2010 | 86 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 492 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 517 | 0.020 |
Why?
|
| Biomarkers | 1 | 2010 | 596 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2005 | 32 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2010 | 1926 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2005 | 341 | 0.010 |
Why?
|